Cargando…
Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients
Early prediction of COVID-19 in-hospital mortality relies usually on patients’ preexisting comorbidities and is rarely reproducible in independent cohorts. We wanted to compare the role of routinely measured biomarkers of immunity, inflammation, and cellular damage with preexisting comorbidities in...
Autores principales: | Lombardi, Carlo, Roca, Elena, Bigni, Barbara, Bertozzi, Bruno, Ferrandina, Camillo, Franzin, Alberto, Vivaldi, Oscar, Cottini, Marcello, D'Alessio, Andrea, Del Poggio, Paolo, Conte, Gian Marco, Berti, Alvise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444380/ https://www.ncbi.nlm.nih.gov/pubmed/34545350 http://dx.doi.org/10.1016/j.crimmu.2021.09.001 |
Ejemplares similares
-
Takotsubo Syndrome Associated with COVID-19
por: Roca, Elena, et al.
Publicado: (2020) -
Using the 6-min walk test to assess the clinical response to mepolizumab and conventional therapy in severe eosinophilic asthma
por: Lombardi, Carlo, et al.
Publicado: (2023) -
The emerging roles of eosinophils: Implications for the targeted treatment of eosinophilic-associated inflammatory conditions
por: Lombardi, Carlo, et al.
Publicado: (2022) -
Obesity is a Major Risk Factor for Hospitalization in Community-Managed COVID-19 Pneumonia
por: Cottini, Marcello, et al.
Publicado: (2021) -
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study
por: Lombardi, Carlo, et al.
Publicado: (2020)